Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

203.55 -0.32 (-0.16%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,564,596
Open 204.37
Bid (Size) 200.91 (1)
Ask (Size) 204.56 (2)
Prev. Close 203.87
Today's Range 202.32 - 204.73
52wk Range 135.85 - 207.32
Shares Outstanding N/A
Dividend Yield 2.91%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
On Friday, Bristol Myers Squibb stock earned an upgrade to its Relative Strength (RS) Rating, from 62 to 79. 
Via Investor's Business Daily
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
The major indexes declined, but haven't fallen apart. 
Via Investor's Business Daily

Performance

YTD
+27.36%
+27.36%
1 Month
+4.14%
+4.14%
3 Month
+10.41%
+10.41%
6 Month
+25.08%
+25.08%
1 Year
+43.93%
+43.93%

More News

Read More
Price Over Earnings Overview: AbbVie
Via Benzinga
Market Analysis: AbbVie And Competitors In Biotechnology Industry
Via Benzinga
AbbVie's Options Frenzy: What You Need to Know
Via Benzinga
Forecasting The Future: 11 Analyst Projections For AbbVie
Via Benzinga
Check Out What Whales Are Doing With ABBV
Via Benzinga
5 Dividend Stocks to Double Up on Right Now -- Plus Some Dividend ETFs
Via The Motley Fool
AbbVie’s Dividend Isn’t As Scary As It Looks
Via Talk Markets
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Via Benzinga
Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday?
Via Benzinga
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
AbbVie Tops Q3 Expectations As Skyrizi, Rinvoq Drive Growth
Via Benzinga
AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
Via Investor's Business Daily
3 Dividend Growth Stocks to Buy and Never Sell
Via The Motley Fool
Biotech Momentum Trades For The Q4 Rally
Via Talk Markets
AbbVie Chart Reflects Bearish Signals Ahead Of Q3 Earnings
Via Benzinga
Sweetgreen, Tesla, Digital Realty Trust And A Health Care Stock On CNBC's 'Final Trades'
Via Benzinga
What Lies In Store For Healthcare ETFs In Q3 Earnings?
Via Talk Markets
Topics ETFs
3 Dividend Growth Stocks You Can Buy and Hold Forever
Via The Motley Fool
3 High-Yielding Dividend Stocks That Can Be Ideal Buys for Retirees
Via The Motley Fool
Beat the Nasdaq With This Cash-Gushing Dividend Stock
Via The Motley Fool
3 Simple Vanguard ETFs to Buy With $1,000 and Hold for a Lifetime
Via The Motley Fool
Topics ETFs
Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise
Via Talk Markets
3 Growth Stocks That Could Be Bargain Buys Right Now
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.